Inactive Instrument

Other languages Titan Pharmaceuticals, Inc. OTC Bulletin Board

Equities

TTNP

US8883141017

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01
Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule	Jan. 26
Titan Pharmaceuticals, Inc. Announces Resignation of Brian Crowley as Senior Vice President, Finance and Administration, Effective February 2, 2024	Jan. 18
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Titan Pharmaceuticals, Inc. Announces Board Changes	23-10-16
Titan Pharmaceuticals Appoints New Chairman of the Board	23-10-16
Titan Pharmaceuticals, Inc. Announces Board Resignations	23-09-19
Fedson, Inc. completed the acquisition of Certain ProNeura Assets of Titan Pharmaceuticals, Inc..	23-08-31
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Titan Pharmaceuticals, Inc. Announces Board Changes	23-07-07
Insider Sell: Titan Pharmaceuticals	23-06-23
Titan Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Titan Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
Titan Pharmaceuticals Signs Letter of Intent for Reverse Merger; Shares Drop	22-12-15
Titan Pharmaceuticals, Inc. Appoints David E. Lazar as Chief Executive Officer, Effective August 16, 2022	22-12-15
Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc	22-12-12
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Titan Pharmaceuticals Appoints David E. Lazar Interim Chairman, CEO; Expands Board After Election of Director Nominees	22-08-16
Titan Pharmaceuticals Announces Executive Changes	22-08-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Titan Pharmaceuticals, Inc. OTC Bulletin Board

Equities

TTNP

US8883141017

Other languages

Filters